< Back to search
Filter
1

Study to Evaluate the Maximal Use of Ruxolitinib Cream in Adult and Adolescent Participants With Hidradenitis Suppurativa

for
Hidradenitis Suppurativa
Location: New York NY, Philadelphia PA, Sweetwater FL, Sanford FL,
Sponsor: Incyte Corporation

Sex: All

Age: 12 - 70+

Code: NCT07049575

Phase1, Recruiting

1726-nm Laser for Acne Inversa (Hidradenitis Suppurativa)

for
Hidradenitis Suppurativa (HS)
Location: Rosemead CA
Sponsor: Wynn Medical Center

Sex: All

Age: 18 - 60

Code: NCT07155239

Phase1, Recruiting

A Long-Term Follow-Up Observational Study to Evaluate Safety in Subjects Who Have Received a Gene-Modified Regulatory T Cell (Treg) Therapeutic

for
Rheumatoid Arthritis (RA), Hidradenitis Suppurativa (HS)
Location: Boston MA, Chicago IL, Aurora CO, Stanford CA,
Sponsor: Sonoma Biotherapeutics, Inc.

Sex: All

Age: 18 - 70+

Code: NCT07123038

Recruiting

Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib

for
Hidradenitis Suppurativa (HS)
Location: Portsmouth NH, Boston MA, Brighton MA, Quebec,
Sponsor: Incyte Corporation

Sex: All

Age: 18+

Code: NCT06855498

Phase3, Recruiting

A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)

for
Moderate to Severe Plaque Psoriasis, Psoriatic Arthritis,
Location: Boston MA, Durham NC, Chapel Hill NC, South Miami FL,
Sponsor: UCB Biopharma SRL

Sex: Female

Age: 18+

Code: NCT06888193

Phase1, Recruiting

Interested in new hidradenitis suppurativa trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Evaluate the Safety and Efficacy of Subcutaneous Siplizumab in the Treatment of Hidradenitis Suppurativa.

for
Hidradenitis Suppurativa
Location: Birmingham AL
Sponsor: University of Alabama at Birmingham

Sex: All

Age: 18+

Code: NCT06326476

Early_phase1, Recruiting
Featured

A Study to Assess Molecular Changes in Adult Participants With Moderate to Severe Hidradenitis Suppurativa or With Moderate to Severe Atopic Dermatitis Receiving Subcutaneous Injections of Lutikizumab

for
Hidradenitis Suppurativa, Atopic Dermatitis
Location: Ann Arbor MI, Sacramento CA
Sponsor: AbbVie

Sex: All

Age: 18 - 70+

Code: NCT06524635

Phase2, Recruiting

A Study to Assess NAV-240 in Adult Participants With Hidradenitis Suppurativa

for
Hidradenitis Suppurativa (HS)
Location: Portsmouth NH, Boston MA, The Bronx NY, Montreal,
Sponsor: Navigator Medicines, Inc.

Sex: All

Age: 18 - 70

Code: NCT07384975

Phase2, Recruiting

Real-world Secukinumab Outcomes in Canadian HS Patients

for
Hidradenitis Suppurativa
Location: St. John's, Fredericton, Richmond Hill, Sherbrooke,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT07282015

Recruiting

Battlefield Acupuncture for Pain in Hidradenitis Suppurativa

for
Hidradenitis Suppurativa
Location: Dearborn MI
Sponsor: Wayne State University

Sex: All

Age: 18+

Code: NCT04218422

Recruiting

Trial to Determine the Immunomodulatory Activity of PTM-001 in Patients With Hidradenitis Suppurativa

for
Hidradenitis Suppurativa
Location: Worcester MA, Cincinnati OH, Redwood City CA
Sponsor: Phoenicis Therapeutics

Sex: All

Age: 18+

Code: NCT05020730

Phase2, Recruiting

A Study to Investigate Efficacy and Safety With SAR445399 in Adult Participants With Moderate to Severe Hidradenitis Suppurativa

for
Hidradenitis Suppurativa
Location: Sherbrooke, New York NY, Montreal, Fort Lauderdale FL,
Sponsor: Sanofi

Sex: All

Age: 18+

Code: NCT07225569

Phase2, Recruiting

Brivekimig for the Treatment of Moderate to Severe Hidradenitis Suppurativa

for
Hidradenitis Suppurativa
Location: Johnston RI, Quebec, Miramar FL, Miami FL, Toronto,
Sponsor: Sanofi

Sex: All

Age: 18+

Code: NCT07170917

Phase2, Recruiting